Exelgen Ltd (CBTE) Announces Partnerships with Two Leading European Biotechnology Companies
Exelgen Ltd, a wholly owned subsidiary of Commonwealth Biotechnologies, Inc. (CBTE), announced that the company has partnered with two leading European-based Biotechnology companies. However, because of the proprietary nature of this collaboration, both companies have declined to be identified or disclose the contract values. Because both companies are focused on a plethora of research activities, this partnership was advantageous for Exelgen. Such research activities include medicinal chemistry research and changes to Exelgen's LeadHopping technology. Mark Warne, Managing Directer of Exelgen, specified, "The decision by these premiere biotechnology companies to select Exelgen as their drug discovery partner underscores the quality of…